Pharma News
Biogen Releases Positive Data from Spinraza Study, Focusing on Infants and Toddlers with Spinal Muscular Atrophy
![](https://meefro.com/wp-content/uploads/2024/03/Biogen-Releases-Positive-Data-from-Spinraza-Study-Focusing-on-Infants-780x470.png)
Results from Phase IV RESPOND study indicate a significant reduction in plasma neurofilament light chain (NfL) levels.
Source link
#Biogen #Releases #Positive #Data #Spinraza #Study #Focusing #Infants #Toddlers #Spinal #Muscular #Atrophy